Early Treatment With Sofosbuvir (SOF) and Ledipasvir (LDV) to Prevent HCV Recurrence After Liver Transplantation (OLT)

NCT02478229 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped difficulty recruiting patients

Conditions

Hepatitis C Viral Infection

Interventions

DRUG: Sofosbuvir (SOF) and Ledipasvir (LDV)

Sponsor

University Health Network, Toronto